Loading...
Symbols:
Loading...
Symbols:
Johnson & Johnson (JNJ)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Johnson & Johnson (JNJ)
406 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on JNJ
- SA Editor Miriam Metzinger(63)
- Bespoke Investment Group(30)
- SA Editor Eli Hoffmann(29)
- SA Editor Joan Wickham(28)
- Geoff Considine(14)
Most popular authors
(tracked in watchlists)
- Philip Davis(543)
- Bespoke Investment Group(528)
- Trader Mark(448)
- Bill Cara(392)
- SA Editor Eli Hoffmann(379)
Most commented on authors
- Bespoke Investment Group(132)
- SA Editor Joan Wickham(89)
- SA Editor Eli Hoffmann(69)
- Geoff Considine(63)
- Dividends4Life (61)
- Regenerative Medicine: Big Pharma's Next Frontier
- Measuring Risk of a Dividends Investment Profile
- Ultra Brite Outlook for Colgate - Barron's
- Is Buy-and-Hold Dead? Hardly
- Thoughts on Market Volatility
- General Electric Moves On Down the Largest Company List
- Fast Money Recap - Will Goldman Be Tarnished? (11/10/08)
- S&P 500 Dividend Aristocrats and Your Portfolio
- Perception: Top Socially Responsible Companies Include Google, Campbell, J&J
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Parsing the Dismal October Employment Report
- ETFI Global Healthcare Sector PerfomIdex
- Dow Price Targets
- A Buy & Hold Forever Dividend Stock Portfolio
- Reality Check on the Big Pharma Rumor Mill
- Johnson & Johnson: Still Adding to My Position
- JP Morgan Analyst: Johnson & Johnson Not Worth the Sum of Its Parts
- Abundant Opportunities in Bear Markets
- 60 Defensive Growth Stocks
- Unfairly Punished - Fast Money Recap (10/24/08)
- Going Cautiously Long
- Bargains Abound in Four Large-Cap Leaders
- Big Pharma Feels Free Market Pain
- People Still Have To Spend: Eleven Dividends for Even Conservative Investors
- Finding Outperformers in a Pay-As-You-Go World
- American Express Surprises - Fast Money Recap (10/20/08)
- Ten Highest Yielding Pharma Stocks
- China Biotech Week in Review: FDA, Deals & Earnings
- Stocks Struggle Around the World
- WuXi Expands J&J Collaboration
- Johnson & Johnson: Is It Too Late?
- Johnson & Johnson Takes Good Care of Business
- Market Behaves Sanely - Fast Money Recap (10/14/08)
- It's Earnings Season: J&J Beats, Pepsi Disappoints
- Johnson & Johnson Earnings Makes Dollars and Stents
- Attractive Dividend Stocks in the Buy Zone
- Earnings Preview: Johnson & Johnson
- Comparing This Past Week to the '87 Crash
- Intuitive Surgical: Medical Device Stocks Look Oversold - But Not Recession Proof
- A Politics-Proof Portfolio
- Single Worst Week - Fast Money Recap (10/10/08)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
2 new today)